Loading...
Loading...
Revium Rx.
Revium Rx.. Spoken Alpha tracks RVRC's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks RVRC's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 90% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for RVRC.
curl https://api.spokenalpha.com/v1/companies/RVRC| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.54 | $2.98 | +18.7% | -3.8% | -6.4% |
| Q4 FY2026 | $3.19 | $2.85 | +11.8% | -1.6% | -3.6% |
| Q3 FY2026 | $3.86 | $3.03 | +27.3% | -7.2% | -7.4% |
| Q2 FY2026 | $3.50 | $2.99 | +17.1% | -7.4% | -6.2% |
| Q1 FY2025 | $3.59 | $3.05 | +17.8% | +0.6% | -1.6% |
| Q4 FY2025 | $3.63 | $3.05 | +18.9% | -5.4% | -5.4% |
| Q3 FY2025 | $3.55 | $2.99 | +18.7% | -2.4% | -3.5% |
| Q2 FY2025 | $3.84 | $3.13 | +22.8% | -5.5% | -6.8% |
| Q1 FY2024 | $3.77 | $2.99 | +26.2% | -1.8% | -3.8% |
| Q4 FY2024 | $3.79 | $3.22 | +17.6% | -6.5% | -7.6% |